Assignment: Quantitative Research Analysis Web Page

profileTina_Brown1582
article3.pdf

APRIL 2018, VOL. 22 NO. 2 CLINICAL JOURNAL OF ONCOLOGY NURSING 203CJON.ONS.ORG

E Aromatherapy The effect of lavender on anxiety and sleep quality in patients treated with chemotherapy

Ayse Özkaraman, RN, PhD, Özlem Dügüm, RN, Hülya Özen Yılmaz, MSc, and Öznur Usta Yeşilbalkan, RN, PhD

ESSENTIAL OILS ARE CHEMICALS EXTRACTED FROM PARTS OF PLANTS that have a unique aroma and complex chemical properties (National Cancer Institute [NCI], 2018; Worwood, 2016). Essential oils can be inhaled, digested, or applied topically, and they are eliminated from the body through urine and by respiration (Maddocks-Jennings & Wilkinson, 2004; NCI, 2018). They were introduced to nursing care by Florence Nightingale, and their use grows daily by nurses with certification in the use of essential oils (Gnatta, Kurebayashi, Turrini, & Silva, 2016; Smith & Kyle, 2008).

Lavender is a member of the mint family and contains linalyl acetate, linalool, and caryophyllene. Lavandula angustifolia increases the effect of gamma-Aminobutyric acid on the amygdala and has narcotic and sedative effects similar to those of benzodiazepines (Conrad & Adams, 2012; Fismer & Pilkington, 2012; Maddocks-Jennings & Wilkinson, 2004). In addition, Lavandula hybrida has relaxing and sedative properties (Price & Price, 2011). In addition to its antibacterial, antifungal, and carminative characteristics, which increase wound healing and the detoxification of enzymes associated with insect bites, lavender has no known contraindications and is safe to use (Braden, Reichow, & Halm, 2009; Howard & Hughes, 2008; Kritsidima, Newton, & Asimakopoulou, 2010; Muzzarelli, Force, & Sebold, 2006). Inhaling lavender has been reported to have an immediate effect, and topical administration takes effect in 10–90 minutes and lasts a few days (Worwood, 2016).

Lavender is used for spiritual relaxation, for therapeutic purposes (to build physical and emotional well-being), and for regulation of sleep disor- ders (Koulivand, Khaleghi Ghadiri, & Gorji, 2013; Kritsidima et al., 2010). In a study conducted by Franco et al. (2016), 2% lavender oil was admin- istered to one group of women and odor-free aromatic oil was given to another group for 10 minutes through an oxygen mask before all under- went a breast biopsy. Women who inhaled lavender oil reported decreased negative feelings, and the aromatherapy was shown to be effective in the management of preoperative anxiety (Franco et al., 2016). Another study showed that smelling four drops of 10% lavender oil for four weeks improved sleep quality in postpartum women (Keshavarz Afshar et al., 2015). Kritsidima at al. (2010) observed the diagnosis and treatment procedures carried out on a group of patients who visited an outpatient clinic for dental treatment in a room where a 10-cc cup of water with 5 drops of lavender oil was located. They observed the procedures con- ducted on another group in an odor-free room. At the end of the study,

KEYWORDS

aromatherapy; lavender; sleep quality;

anxiety; PSQI; STAI; chemotherapy

DIGITAL OBJECT IDENTIFIER

10.1188/18.CJON.203-210

BACKGROUND: A cancer diagnosis is a serious

stressor that is associated with anxiety, depression,

sleep disorders, and inability to fulfill daily routines.

Many pharmacologic and nonpharmacologic

options are available to help patients with cancer

manage anxiety.

OBJECTIVES: This randomized, controlled trial

examined the effects of lavender oil aromatherapy

on anxiety and sleep quality in patients undergoing

chemotherapy.

METHODS: 70 patients were randomly assigned

to a lavender oil group, a tea tree oil group, and a

control group with no oil. A patient identification

form, the State-Trait Anxiety Inventory, and the

Pittsburgh Quality Sleep Index (PSQI) were used to

measure anxiety and sleep quality before and after

chemotherapy.

FINDINGS: State anxiety before and after chemo-

therapy did not vary among groups. The authors

compared trait anxiety values before and after

chemotherapy and found a significant difference in

the lavender group. In addition, a significant change

in PSQI measurements before and after chemother-

apy was observed.

204 CLINICAL JOURNAL OF ONCOLOGY NURSING APRIL 2018, VOL. 22 NO. 2 CJON.ONS.ORG

AROMATHERAPY

“The use of lavender oil significantly increased the sleep quality of patients with cancer.”

they found that the anxiety levels of the patients undergoing procedures in the room with the lavender aromatherapy were lower (Kritsidima et al., 2010). Although lavender oil is used for the management of anxiety and sleep disorders in varied populations, no studies to date have reported on the efficacy of lavender oil to better manage anxiety and sleep disorders in patients undergoing chemotherapy.

Patients with cancer experience symptoms from their disease and treatment, including fear of death, poor quality of life, and damaged relationships, which can cause a feeling of a loss of con- trol, anxiety, and sleep disorders (Chandwani et al., 2012; Chang & Lin, 2017; Delsigne, 2013; Graci, 2005; NCI, 2016; Palesh et al., 2010; Yaranoğlu, 2015). Oncology nurses play an important role in the pharmacologic and nonpharmacologic management of anxiety and sleep disorders. Many pharmacologic treatments are used to manage anxiety and sleep disorders, but they can lead to adverse effects and economic loss (NCI, 2016). Nonpharmacologic treat- ments that are effective in treating anxiety and sleep disorders include participating in relaxation exercises, listening to music, shifting attention, practicing sleep hygiene, and using aroma- therapy (Cramer, Lauche, Langhorst, Dobos, & Paul, 2013; Dóro, Neto, Cunha, & Dóro, 2017; Emberly, 2008; Firmeza et al., 2017; Gallagher, Lagman, & Rybicki, 2017; Ovayolu, Seviğ, Ovayolu, & Sevinç, 2014; Zupanec et al., 2017). The current study was designed to evaluate the effects of lavender oil on anxiety and sleep quality in patients receiving chemotherapy.

Methods Participants The study sample consisted of patients with cancer who were receiving chemotherapy in outpatient units. Inclusion criteria were as follows: patients with cancer aged 18 years or older who had the ability to smell, were receiving paclitaxel weekly, agreed not to use scented products, and volunteered to participate in the study. The exclusion criteria included having a chronic disease (cardiovascular disease, asthma), being diagnosed with a psychi- atric disease (anxiety, panic attacks, depression), having a known history of allergies, and using anxiolytic drugs.

Outcome Measures For the collection of data, the researchers used a patient iden- tification form created for the study, The State-Trait Anxiety Inventory (STAI), and the Pittsburgh Sleep Quality Index (PSQI).

The patient identification form included questions about patients’ socio-demographic characteristics (age, sex, educa- tional status, marital status, information about caregivers), sleep characteristics (room temperature, sound, light, day and night sleep durations), and disease characteristics (diagnosis, treat- ment, and duration of disease).

The STAI is a self-evaluation questionnaire that uses short statements to evaluate how participants feel in a certain time

or under a certain condition. It was adapted to Turkish by Öner and Le Compte (1985) and was used in this study. It has two sub- scales, the State Anxiety Scale (S-Anxiety) and the Trait Anxiety Scale (T-Anxiety), which are measured by a four-point Likert- type scale ranging from 1 (never) to 4 (always). According to reliability analysis, the Cronbach alpha internal consistency coef- ficients are from 0.94–0.96 for the S-Anxiety and from 0.83-0.87 for the T-Anxiety, respectively (Kara & Acet, 2012; Şirin, Kavlak, & Ertem, 2003). The STAI clearly differentiates between the temporary condition of state anxiety and the more general and long-standing quality of trait anxiety, helping professionals dis- tinguish between feelings of anxiety and depression.

The PSQI was developed by Buysse, Reynolds, Monk, Berman, and Kupfer (1989), and Ağargün, Kara, and Anlar (1996) performed its validity and reliability analyses in Turkey. The Turkish version was used in this study. Although the PSQI consists of 24 items, it is scored using 19 items. It includes open-ended questions, such as “During the past month, when have you usually gone to bed at night?” as well as multiple-choice questions, such as “During the past month, how would you rate your sleep quality overall?” with answers ranging from 0 (very good) to 3 (very bad) or 0 (not during the past month) to 3 (three or more times a week). It has 7 components, each scored from 0–3. Total scores range from 0–21 points. Scores lower than five points indicate good sleep quality, and scores higher than five points indicate poor sleep quality (Ağargün et al., 1996).

Data Collection Before initiating this study, the researchers obtained written per- mission from the ethical committee and administration of the Private Ümit Hospital in Eskişehir, Turkey. After the researchers recruited patients who met the criteria, they obtained written consent. Using the random-number method on a computer, the authors randomized participants to one of three groups (lavender oil group, tea tree oil group, or control group). The patients were homogeneously distributed across groups, and the data were collected by a nurse who was independent of the research team. The patients’ records and group numbers were delivered to the

APRIL 2018, VOL. 22 NO. 2 CLINICAL JOURNAL OF ONCOLOGY NURSING 205CJON.ONS.ORG

CJON.ONS.ORG

administering nurse in a closed envelope. Numbered labels were affixed to the bottles of aromatic oils to blind the contents of the bottles to patients and the administering nurse.

The researchers bought the lavender essential oil (Lavandula hybrida) from an herbal product firm with quality certifications, consisting of business registration G06-3231 from the Ministry of Food, Agriculture, and Livestock, and ISO 9001:2008 from the International Organization for Standardization. The tea tree oil used in the current study was bought from the same herbal product firm. In their study, Howard and Hughes (2008) used tea tree oil, which does not have a sedative or relaxing effect, to create a placebo effect, as it was used in the current study.

In the first and second stages of the study, lavender oil and tea tree oil were administered to the respective intervention groups, and no aromatherapy was administered to the control group. Three drops of lavender or tea tree oil were put onto a piece of cotton that was placed on each patient’s neck and shoulders, about 10 inches below the nose.

FIRST ASSESSMENT: The authors used a patient identification form, the STAI (T-Anxiety and S-Anxiety), and the PSQI for the first evaluation of all groups just before the first cycle of chemo- therapy. During chemotherapy, the nurse administered lavender and tea tree oil to the respective intervention groups. No aroma- therapy was administered to the patients in the control group. When the patients completed chemotherapy, the S-Anxiety was readministered to all patients.

SECOND ASSESSMENT: The nurse gave written and verbal information about the use of lavender or tea tree oil at home to patients in the respective intervention groups when they were discharged after chemotherapy. For one month, the lavender group patients and tea tree oil patients smelled the oil every night at 9 pm for five minutes at home. After chemotherapy, the T-Anxiety and PSQI were readministered, and a second evalua- tion was performed.

Statistical Methods and Data Analysis Descriptive statistics for quantitative variables were calculated and presented as a mean and standard deviation. Frequencies and percentages were given for qualitative variables, and the Shapiro-Wilk test was used to evaluate the normality of quan- titative variables. Scores from the scales were assessed with two-way mixed analysis of variance (ANOVA) using general linear models for repeated measures procedure from IBM SPSS Statistics, version 21.0. The model included group and time as main effects and a group * time interaction effect term. Post hoc testing was carried out only for significant interactions and was performed using a simple effect analysis with Bonferroni adjustment. The relationship between categorical variables was evaluated using Pearson chi-square analysis. A probability value of less than 0.05 was considered significant, unless otherwise noted.

Findings Sample Characteristics Of the participants, 30 were in the lavender group, 20 were in the tea tree oil group, and 20 were in the control group. The mean age of the participants was 58.22 years. Most were women and were married, and about half were graduates of primary school. The distribution of patients by age, sex, educational status, mar- ital status, and income level was homogeneous (p < 0.05) (see Table 1). In addition, 10 expressed that their income met their expenses, most had breast cancer, 22 were undergoing paclitaxel- carboplatin treatment, and 7 had not experienced any symptoms in the past week.

State-Trait Anxiety Inventory Scores According to the S-Anxiety and T-Anxiety scores from the first assessment before chemotherapy, all patients had moderate state and trait anxiety. In the second assessment, S-Anxiety and T-Anxiety mean scores decreased in all groups.

Table 2 shows descriptive statistics. In terms of S-Anxiety values, no difference was found among groups (F[2.67] = 1.16 , p = 0.32). The authors did not find a significant change in S-Anxiety values from the first to second assessment (F[1.67] = 1.981, p = 0.164). The change that occurred between S-Anxiety values from the first to second assessment did not vary by group (F[2.67] = 0.826, p = 0.442). The authors did not perform power analysis because no significant difference existed in group, time, or group * time interaction.

The model established for T-Anxiety showed that no dif- ference existed among all groups (F[2.67] = 1.246, p = 0.294); however, considering all participants, a significant change in T-Anxiety values was observed from the first to second assess- ment (F[1.67] = 9.595, p = 0.003), which also differed among groups (F[2.67] = 11.002, p < 0.001). The researchers examined reasons for this difference and determined that, when the groups were compared at the first and second assessments, there was a difference only between the lavender and tea tree oil groups at the second assessment (p = 0.046). However, when comparing group measurements at the first and second assessments, a sig- nificant difference was found only between measurements for the lavender group (p < 0.001). The posterior power of these compar- isons performed in terms of the group * time interaction was 98%.

Pittsburgh Sleep Quality Index Scores In the first assessment performed before chemotherapy, the PSQI mean score for each group was higher than five points; in the second assessment after chemotherapy, the PSQI mean score decreased only in the lavender and tea tree oil groups (PSQI: L = 3.86 [SE = 0.58], T = 5.9 [SE = 0.722], C = 7.15 [SE = 0.722]).

Given all measurements obtained in this study, no differ- ence existed among groups in terms of PSQI (F[2.67] = 1.721, p = 0.187); however, the researchers found a significant change

206 CLINICAL JOURNAL OF ONCOLOGY NURSING APRIL 2018, VOL. 22 NO. 2 CJON.ONS.ORG

AROMATHERAPY

TABLE 1.

SAMPLE CHARACTERISTICS

LAVENDER GROUP (N = 30)

TEA TREE GROUP (N = 20)

CONTROL (N = 20)

TOTAL (N = 70)

CHARACTERISTIC — X SE

— X SE

— X SE

— X SE p

Age (years) 57.73 12.81 57.55 12.87 59.65 13.37 58.22 12.83 > 0.05

CHARACTERISTIC n n n n

Sex (c2 = 0.917) 0.653

Female 24 17 18 59

Male 6 3 2 11

Educational status (c2 = 0.633) 0.386

Primary school 15 7 11 33

Secondary school 7 9 5 21

High school 4 2 4 10

Literate 4 2 – 6

Marital status (c2 = 0.243) 0.877

Married 24 15 15 54

Single 6 5 5 16

Income level (c2 = 3.118) 0.596

Income meets expenditure 23 15 17 55

Income exceeds expenditure 6 3 1 10

Income does not meet expenditure 1 2 2 5

Cancer type –

Breast 18 12 16 46

Lung 6 3 2 11

Urothelial 1 – 1 2

Ovarian 3 2 1 6

Gastrointestinal 2 – – 2

Unknown origin – 2 – 2

Renal – 1 – 1

Chemotherapy –

Paclitaxel and carboplatin 11 7 4 22

Paclitaxel and trastuzumab 10 7 7 24

Continued on the next page

APRIL 2018, VOL. 22 NO. 2 CLINICAL JOURNAL OF ONCOLOGY NURSING 207CJON.ONS.ORG

between the first and second measurement values (F[1.67] = 33.162, p < 0.001), which also differed among groups (F[2.67] = 8.991, p < 0.001). In terms of measurement time, this study revealed a significant difference in measurements between the lavender and control groups only at the second assessment. The group comparisons showed a significant difference between measurements at the first and second assessments for the lav- ender and tea tree oil groups (p < 0.001). The posterior power of these comparisons in terms of the group * time interaction was 95%.

Discussion The use of lavender oil in different therapeutic activities has been explored by various studies (Kianpour, Mansouri, Mehrabi, & Asghari, 2016; Koca Kutlu, Yılmaz, & Çeçen, 2008; Maddocks- Jennings & Wilkinson, 2004; Ovayolu et al., 2014; Smith & Kyle, 2008; Takeda, Watanuki, & Koyama, 2017). Several studies sup- port the ongoing use of lavender oil as part of an integrated approach to invasive interference (Karadag, Samancioglu, Ozden, & Bakir, 2017; Trambert, Kowalski, Wu, Mehta, & Friedman, 2017). Aromatherapy massage with lavender oil has had positive effects on patients with cancer (Ovayolu et al., 2014). In the cur- rent study, trait anxiety was reduced and sleep quality improved with the use of lavender oil.

The first assessment revealed that the sleep quality of each group was poor prior to the use of the oils and that partici- pants experienced a moderate level of state and trait anxiety.

The present study evaluated the immediate anxiety levels of the patients and revealed that the medium level of state anx- iety observed in the control group before chemotherapy did not change, along with the state anxiety levels of the two groups that smelled lavender oil and tea tree oil during chemotherapy. No difference was found the state anxiety levels among groups. A study examining the effects of one drop of Lavandula hybrida oil before surgical operations by Braden et al. (2009) revealed that it reduced patients’ state anxiety. Other studies have also found that the inhalation of lavender oil reduces state anxiety (Koca Kutlu et al., 2008; Kritsidima et al., 2010). However, the current study revealed no effect of Lavandula hybrida oil (three drops) on participants’ state anxiety, which was largely in agreement with the findings of other studies (Howard & Hughes, 2008; Perry, Terry, Watson, & Ernst, 2012).

A study by Bikmoradi et al. (2015) revealed that smelling lavender for 20 minutes two days per week did not reduce par- ticipants’ anxiety, and these researchers suggested increasing the duration of aromatherapy to determine the effect of lavender. In the current study, results did not indicate a significant difference in state anxiety levels because the S-Anxiety was administered to patients before and after chemotherapy, the time between these two administrations was short according to chemotherapy pro- tocols (a minimum of one hour and a maximum of four hours), and the patients may have given the same responses at the first and second assessments because they remembered their prior answers. The time invariance of scales defines the relationship

TABLE 1. (CONTINUED)

SAMPLE CHARACTERISTICS

LAVENDER GROUP (N = 30)

TEA TREE GROUP (N = 20)

CONTROL (N = 20)

TOTAL (N = 70)

CHARACTERISTIC n n n n p

Chemotherapy (continued) –

Paclitaxel 3 5 4 12

Paclitaxel, trastuzumab, and carboplatin

5 – 5 10

Paclitaxel and gemcitabine 1 1 – 2

Symptoms experienced in the past week

Fatigue and weakness 11 15 8 34

Anorexia, fatigue, and pain 15 2 4 21

Numbness in hands and feet 1 1 5 7

None 3 2 3 8

SE—standard error

208 CLINICAL JOURNAL OF ONCOLOGY NURSING APRIL 2018, VOL. 22 NO. 2 CJON.ONS.ORG

among datasets obtained by measuring anything in different time periods under similar conditions (Karasar, 2005). In the current study, the time invariance criterion of the S-Anxiety was not met.

The current study also showed no difference in trait anx- iety levels among patients in the tea tree oil and control groups at the first and second assessments, whereas the trait anxiety levels of patients in the lavender group decreased by the second assessment. Published studies have reported that, because of its anxiolytic and sedative effects (Conrad & Adams, 2012; Fismer & Pilkington, 2012; Kianpour et al., 2016; Maddocks-Jennings & Wilkinson, 2004; Woelk & Schläfke, 2010), lavender provides spiritual comfort and physical and emotional well-being (Franco et al., 2016; Hur, Song, Lee, & Lee, 2014; Koulivand et al., 2013; Redstone, 2015). Ovayolu et al. (2014) found that aromatherapy massage and aromatherapy with lavender oil maintain physical comfort in the short term and that lavender oil can be used to manage psychological problems in the long term. Essential com- pounds, such as linalool and linalyl acetate in lavender oil, are linked to receptors in the olfactory bulb by smelling, and a ther- apeutic effect arises in the area where actions and moods, such as fear and anger, are controlled and motivated in the limbic system (Huang & Capdevila, 2017; Koulivand et al., 2013; Lis- Balchin & Hart, 1999; Maddocks-Jennings & Wilkinson, 2004; NCI, 2018). The current study determined that lavender oil is effective in managing anxiety if it is regularly used every day for a month. Patients expressed satisfaction with the pleasant aroma of lavender in the room when administered during chemotherapy.

The current study revealed that the use of lavender signifi- cantly increased the sleep quality of patients with cancer based on the assessment time compared to the other two groups. The sleep quality of patients in the tea tree oil group increased in the second assessment compared to the first assessment; however, no statistical difference was found between the lavender and con- trol groups. As with other studies (Karadag et al., 2017; Keshavarz Afshar et al., 2015), the current study revealed that the use of lav- ender oil improved sleep quality.

Otaghi, Qavam, Norozi, Borji, and Moradi (2017) found that essential lavender oil was not effective in improving sleep quality. However, Otaghi et al. (2017) did not report on the anxiety level of patients. There is a negative relationship between sleep quality and anxiety. In the current study, patients began to relax, revealed by a decrease in trait anxiety, and their sleep quality improved. Tea tree oil had no effect on state and trait anxiety levels but did increase sleep quality. The current authors hypothesized that tea tree oil had a placebo effect; statistical analyses confirmed the superiority of lavender oil in improving sleep quality.

Limitations The study is limited to patients who were treated with weekly paclitaxel and who completed the STAI and PSQI. The effects

TABLE 2.

DESCRIPTIVE STATISTICS OF STAI AND PSQI SCORES BY GROUP AND TIME

LAVENDER GROUP TEA TREE GROUP CONTROL p

GROUP AND TIME — X SE

— X SE

— X SE TIME GROUP GROUP * TIME

S-Anxiety 0.164 0.320 0.442

First assessment 41.4 1.49 45.3 1.82 42 1.82

Second assessment 42.36 1.53 45.3 1.88 42.4 1.88

T-Anxiety 0.003 0.294 < 0.001

First assessment 44.8 1.27 45.4 1.556 45.4 1.556

Second assessment 40.833 1.123 45.25 1.376 45.25 1.376

PSQI < 0.001 0.187 < 0.001

First assessment 7.63 0.82 9.15 1.009 7.05 1.009

Second assessment 3.86 0.58 5.9 0.722 7.15 0.722

PSQI—Pittsburgh Sleep Quality Index; S-Anxiety—State Anxiety Scale; SE—standard error; STAI—State-Trait Anxiety Inventory; T-Anxiety—Trait Anxiety Scale

IMPLICATIONS FOR PRACTICE

ɔ Evaluate patients’ anxiety and sleep states during treatment. ɔ Use lavender oil, which has a pleasant smell, has no adverse effects,

and is inexpensive, in the management of patients’ anxiety and

sleep disorders. ɔ Apply knowledge about the use of aromatherapy in nursing

practice.

AROMATHERAPY

APRIL 2018, VOL. 22 NO. 2 CLINICAL JOURNAL OF ONCOLOGY NURSING 209CJON.ONS.ORG

of lavender oil inhalation on anxiety and sleep quality should be evaluated in a larger population who receive other chemo- therapy protocols. Although the authors tried to blind the nurse and patients to the aromatic oils used in the study, blinding failed because participants were familiar with the scent of lavender.

Implications for Nursing and Conclusion The current study showed that the patients treated with che- motherapy had a medium level of state and trait anxiety and a low level of sleep quality. The patients treated with tea tree and lavender oil had no complaints associated with the application of oils in the study. This study determined that three drops of lavender oil inhaled nightly before sleep reduced patients’ trait anxiety levels and improved sleep quality.

As a result, oncology nurses should regularly assess patients’ anxiety and sleep status, learn about complementary treatment methods for the management of anxiety and sleep disorders, and include lavender oil during care. Lavender oil has no adverse effects, and it is more cost effective than other complementary methods.

Ayse Özkaraman, RN, PhD, is a lecturer in the Faculty of Health Sciences and

Department of Nursing at Eskişehir Osmangazi University; Özlem Dügüm, RN, is

a charge nurse at the Private Ümit Hospital in Eskişehir; Hülya Özen Yılmaz, MSc,

is a research assistant in the Faculty of Medicine and Department of Biostatistics

at Eskişehir Osmangazi University; and Öznur Usta Yeşilbalkan, RN, PhD, is an

associate professor in the Faculty of Nursing and Department of Internal Diseases

at Ege University in İzmir, all in Turkey. Ozkaraman can be reached at aozaydin26@

hotmail.com, with copy to [email protected]. (Submitted May 2017. Accepted

August 9, 2017.)

The authors take full responsibility for this content. This research was funded in part by the

Scientific Research Project Coordination Unit at Eskişehir Osmangazi University. The article has

been reviewed by independent peer reviewers to ensure that it is objective and free from bias.

REFERENCES

Ağargün, M.Y., Kara, H., & Anlar, Ö. (1996). The validity and reliability of the Pittsburgh Sleep

Quality Index [Article in Turkish]. Türk Psikiyatri Dergisi, 7, 107–115.

Bikmoradi, A., Seifi, Z., Poorolajal, J., Araghchian, M., Safiaryan, R., & Oshvandi, K. (2015). Effect

of inhalation aromatherapy with lavender essential oil on stress and vital signs in patients

undergoing coronary artery bypass surgery: A single-blinded randomized clinical trial.

Complementary Therapies in Medicine, 23, 331–338. https://doi.org/10.1016/j.ctim

.2014.12.001

Braden, R., Reichow, S., & Halm, M.A. (2009). The use of the essential oil lavandin to reduce

preoperative anxiety in surgical patients. Journal of Perianesthesia Nursing, 24, 348–355.

https://doi.org/10.1016/j.jopan.2009.10.002

Buysse, D.J., Reynolds, C.F., 3rd, Monk, T.H., Berman, S.R., & Kupfer, D.J. (1989). The Pittsburgh

Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry

Research, 28, 193–213.

Chandwani, K.D., Ryan, J.L., Peppone, L.J., Janelsins, M.M., Sprod, L.K., Devine, K., . . . Mustian,

K.M. (2012). Cancer-related stress and complementary and alternative medicine: A review.

Evidence-Based Complementary and Alternative Medicine, 2012, 979213. https://doi.org/

10.1155/2012/979213

Chang, W.-P., & Lin, C.-C. (2017). Changes in the sleep-wake rhythm, sleep quality, mood, and

quality of life of patients receiving treatment for lung cancer: A longitudinal study. Chrono-

biology International, 34, 451–461. https://doi.org/10.1080/07420528.2017.1293678

Conrad, P., & Adams, C. (2012). The effects of clinical aromatherapy for anxiety and depression

in the high risk postpartum woman—A pilot study. Complementary Therapies in Clinical

Practice, 18, 164–168. https://doi.org/10.1016/j.ctcp.2012.05.002

Cramer, H., Lauche, R., Langhorst, J., Dobos, G., & Paul, A. (2013). Characteristics of patients

with internal diseases who use relaxation techniques as a coping strategy. Complementary

Therapies in Medicine, 21, 481–486. https://doi.org/10.1016/j.ctim.2013.08.001

Delsigne, J. (2013). Managing sleep disorders in cancer patients. Oncology, 58(2), 4–5.

Dóro, C.A., Neto, J.Z., Cunha, R., & Dóro, M.P. (2017). Music therapy improves the mood of

patients undergoing hematopoietic stem cells transplantation (controlled randomized study).

Supportive Care in Cancer, 25, 1013–1018. https://doi.org/10.1007/s00520-016-3529-z

Emberly, J.A.M. (2008). Relaxation therapy for those with cancer: A grounded theory [Master’s

thesis]. University of Manitoba, Winnipeg, Canada. Retrieved from http://search.proquest

.com/docview/304402197/fulltextPDF/EFD616E9BDCB471CPQ/3?accountid=16716

Firmeza, M.A., Rodriques, A.B., Melo, G.A.A., Aguiar, M.I.F., Cunha, G.H., Oliveira, P.P., & Moura

Grangeiro, A.S. (2017). Control of anxiety through music in a head and neck outpatient

clinic: A randomized clinical trial. Revista da Escola de Enfermagem da USP, 51, e03201.

https://doi.org/10.1590/s1980-220x2016030503201

Fismer, K.L., & Pilkington, K. (2012). Lavender and sleep: A systematic review of the evidence.

European Journal of Integrative Medicine, 4, e436–e447. https://doi.org/10.1016/j.eujim

.2012.08.001

Franco, L., Blanck, T.J.J., Dugan, K., Kline, R., Shanmugam, G., Galotti, A., . . . Wajda, M. (2016).

Both lavender fleur oil and unscented oil aromatherapy reduce preoperative anxiety in

breast surgery patients: A randomized trial. Journal of Clinical Anesthesia, 33, 243–249.

https://doi.org/10.1016/j.jclinane.2016.02.032

Gallagher, L.M., Lagman, R., & Rybicki, L. (2017). Outcomes of music therapy interventions on

symptom management in palliative medicine patients. American Journal of Hospice and

Palliative Medicine, 35, 250–257. https://doi.org/10.1177/1049909117696723

Gnatta, J.R., Kurebayashi, L.F.S., Turrini, R.N.T., & Silva, M.J.P. (2016). Aromatherapy and nursing:

Historical and theoretical conception [Article in Portuguese]. Revista da Escola de Enferma-

gem da USP, 50, 130–136. https://doi.org/10.1590/S0080-623420160000100017

Graci, G. (2005). Pathogenesis and management of cancer-related insomnia. Journal of

Supportive Oncology, 3, 349–359.

Howard, S., & Hughes, B.M. (2008). Expectancies, not aroma, explain impact of lavender aro-

matherapy on psychophysiological indices of relaxation in young healthy women. British

Journal of Health Psychology, 13, 603–617. https://doi.org/10.1348/135910707X238734

Huang, L., & Capdevila, L. (2017). Aromatherapy improves work performance through balanc-

ing the autonomic nervous system. Journal of Alternative and Complementary Medicine,

23, 214–221. https://doi.org/10.1089/acm.2016.0061

Hur, M.-H., Song, J.-A., Lee, J., & Lee, M.S. (2014). Aromatherapy for stress reduction in healthy

adults: A systematic review and meta-analysis of randomized clinical trials. Maturitas, 79,

362–369. https://doi.org/10.1016/j.maturitas.2014.08.006

Kara, H., & Acet, M. (2012). Investigation effect of the state anxiety level of sports managers on

automatic thoughts [Article in Turkish]. E-Journal of New World Sciences Academy, 7(4),

244–258.

Karadag, E., Samancioglu, S., Ozden, D., & Bakir, E. (2017). Effects of aromatherapy on sleep

210 CLINICAL JOURNAL OF ONCOLOGY NURSING APRIL 2018, VOL. 22 NO. 2 CJON.ONS.ORG

AROMATHERAPY

quality and anxiety of patients. Nursing in Critical Care, 22, 105–112. https://doi.org/

10.1111/nicc.12198

Karasar, N. (2005). Scientific research methods (14th ed.) [Book in Turkish]. Ankara, Turkey:

Nobel Yayinlari Press.

Keshavarz Afshar, M., Behboodi Moghadam, Z., Taghizadeh, Z., Bekhradi, R., Montazeri, A., &

Mokhtari, P. (2015). Lavender fragrance essential oil and the quality of sleep in postpartum

women. Iranian Red Crescent Medical Journal, 17(4), e25880. https://doi.org/10.5812/

ircmj.17(4)2015.25880

Kianpour, M., Mansouri, A., Mehrabi, T., & Asghari, G. (2016). Effect of lavender scent inhalation

on prevention of stress, anxiety and depression in the postpartum period. Iranian Journal of

Nursing and Midwifery Research, 21, 197–201. https://doi.org/10.4103/1735-9066.178248

Koca Kutlu, A., Yılmaz, E., & Çeçen, D. (2008). Effects of aroma inhalation on examination anxiety.

Teaching and Learning in Nursing, 3(4), 125–130. https://doi.org/10.1016/j.teln.2008.04.005

Koulivand, P.H., Khaleghi Ghadiri, M., & Gorji, A. (2013). Lavender and the nervous system.

Evidence-Based Complementary and Alternative Medicine, 2013, 681304. https://doi.org/

10.1155/2013/681304

Kritsidima, M., Newton, T., & Asimakopoulou, K. (2010). The effects of lavender scent on dental

patient anxiety levels: A cluster randomised-controlled trial. Community Dentistry and Oral

Epidemiology, 38, 83–87. https://doi.org/10.1111/j.1600-0528.2009.00511.x

Lis-Balchin, M., & Hart, S. (1999). Studies on the mode of action of the essential oil of lavender

(Lavandula angustifolia P. Miller). Phytotherapy Research, 13, 540–542.

Maddocks-Jennings, W., & Wilkinson, J.M. (2004). Aromatherapy practice in nursing: Literature

review. Journal of Advanced Nursing, 48, 93–103. https://doi.org/10.1111/j.1365-2648

.2004.03172.x

Muzzarelli, L., Force, M., & Sebold, M. (2006). Aromatherapy and reducing preprocedural

anxiety: A controlled prospective study. Gastroenterology Nursing, 29, 466–471.

National Cancer Institute. (2016). Sleep disorders (PDQ®)—Health professional version.

Retrieved from https://www.cancer.gov/about-cancer/treatment/side-effects/sleep

-disorders-hp-pdq#section/_10.14.07.2015

National Cancer Institute. (2018). Aromatherapy and essential oils (PDQ®)—Health professional

version. Retrieved from http://www.cancer.gov/about-cancer/treatment/cam/hp/

aromatherapy-pdq

Öner, N., & Le Compte, A.W. (1985). Durumluk-sürekli kaygı envanteri el kitabı [State-Trait

Anxiety Inventory manual]. Istanbul, Turkey: Boğaziçi University Press.

Otaghi, M., Qavam, S., Norozi, S., Borji, M., & Moradi, M. (2017). Investigating the effect of

lavender essential oil on sleep quality in patients candidates for angiography. Biomedical

and Pharmacology Journal, 10, 473–478. https://doi.org/10.13005/bpj/1132

Ovayolu, Ö., Seviğ, Ü., Ovayolu, N., & Sevinç, A. (2014). The effect of aromatherapy and

massage administered in different ways to women with breast cancer on their symptoms

and quality of life. International Journal of Nursing Practice, 20, 408–417. https://doi.org/

10.1111/ijn.12128

Palesh, O.G., Roscoe, J.A., Mustian, K.M., Roth, T., Savard, J., Ancoli-Israel, S., . . . Morrow, G.R.

(2010). Prevalence, demographics, and psychological associations of sleep disruption

in patients with cancer: University of Rochester Cancer Center-Community Clinical

Oncology Program. Journal of Clinical Oncology, 28, 292–298. https://doi.org/10.1200/

JCO.2009.22.5011

Perry, R., Terry, R., Watson, L.K., & Ernst, E. (2012). Is lavender an anxiolytic drug? A systematic

review of randomised clinical trials. Phytomedicine, 19, 825–835. https://doi.org/10.1016/

j.phymed.2012.02.013

Price, S., & Price, L. (Eds.). (2011). Aromatherapy for health professionals (4th ed.). London,

England: Elsevier.

Redstone, L. (2015). Mindfulness meditation and aromatherapy to reduce stress and anxiety.

Archives of Psychiatric Nursing, 29, 192–193. https://doi.org/10.1016/j.apnu.2015.03.001

Şirin, A., Kavlak, O., & Ertem, G. (2003). Determination of the state-trait anxiety levels of

students who are on labour room in maternity hospital [Article in Turkish]. Journal of

Cumhuriyet University School of Nursing, 7, 28–32.

Smith, M.C., & Kyle, L. (2008). Holistic foundations of aromatherapy for nursing. Holistic Nurs-

ing Practice, 22, 3–9. https://doi.org/10.1097/01.HNP.0000306321.03590.32

Takeda, A., Watanuki, E., & Koyama, S. (2017). Effects of inhalation aromatherapy on symptoms

of sleep disturbance in the elderly with dementia. Evidence-Based Complementary and

Alternative Medicine, 2017, 1902807. https://doi.org/10.1155/2017/1902807

Trambert, R., Kowalski, M.O., Wu, B., Mehta, N., & Friedman, P. (2017). A randomized controlled

trial provides evidence to support aromatherapy to minimize anxiety in women undergoing

breast biopsy. Worldviews on Evidence-Based Nursing, 14, 394–402. https://doi.org/

10.1111/wvn.12229

Woelk, H., & Schläfke, S. (2010). A multi-center, double-blind, randomised study of the laven-

der oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.

Phytomedicine, 17, 94–99. https://doi.org/10.1016/j.phymed.2009.10.006

Worwood, V.A. (2016). The complete book of essential oils and aromatherapy (rev. ed). Novato,

CA: New World Library.

Yaranoğlu, C. (2015). Determining the effect of sleep quality and fatigue to functional status in

lung cancer patients receiving chemotherapy. Paper presented at the 21st National Cancer

Congress, Antalya, Turkey.

Zupanec, S., Jones, H., McRae, L., Papaconstantinou, E., Weston, J., & Stremler, R. (2017). A

sleep hygiene and relaxation intervention for children with acute lymphoblastic leukemia: A

pilot randomized controlled trial. Cancer Nursing, 40, 488–496.

Copyright of Clinical Journal of Oncology Nursing is the property of Oncology Nursing Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.